Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Two rare bald spots on the back of the scalp were found to be lupus, not alopecia areata.

New therapies for alopecia areata show potential but need more research.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

Platelet-Rich Plasma (PRP) may help improve hair density in primary cicatricial alopecias (PCAs) patients, but more trials are needed to confirm its benefits.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Hair transplantation can successfully treat stubborn alopecia areata.

No treatment showed significant long-term hair growth benefits for alopecia areata.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.

Dupilumab for eczema may cause hair loss.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

New alopecia treatments aim for better results and fewer side effects.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Propionibacterium acnes might be linked to hair casts and possibly alopecia.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.